Cannabinoid screening matters in youth psychosis evaluations

Medical workup in pediatric first psychotic presentation: real-world diagnostic utility in a large tertiary cohort.

European child & adolescent psychiatry • • Related
🤖

AI Summary

This retrospective study examined the medical evaluation of 235 children and adolescents aged 5–18 presenting with a first psychotic episode at a tertiary medical center. Urine toxicology found substance-related results in 19 patients (8.1%), predominantly involving cannabinoids. These findings highlight the practical value of toxicology screening when young people develop psychotic symptoms, although a positive result does not by itself prove that cannabis caused the episode.

Routine laboratory tests did not otherwise identify an underlying medical cause. Neuroimaging produced clinically explanatory findings in 3 patients (1.3%), and these patients had neurological abnormalities or atypical features; EEG did not identify the cause of psychosis in any case. The authors therefore support a selective, clinically guided workup, with toxicology testing and further neurological investigations based on the individual’s symptoms rather than extensive routine testing for every patient.

💡 Key Findings

1
Urine toxicology identified substance-related findings in 19 patients (8.1%), predominantly cannabinoids, supporting toxicology screening during a first psychotic presentation.
Good
75%
2
Routine laboratory testing did not identify an underlying medical cause, while two cases involved corticosteroid-induced psychosis.
Good
72%
3
Neuroimaging rarely found an explanatory abnormality—3 patients (1.3%)—and these patients had neurological abnormalities or atypical clinical features.
Good
78%
4
EEG did not identify the cause of psychosis in any case, supporting a selective rather than routine extensive workup when neurological warning signs are absent.
Good
78%

📄 Original Abstract

The medical evaluation of children and adolescents with first psychotic presentation aims to identify potentially reversible underlying medical conditions. However, recommendations regarding the extent of diagnostic investigations remain inconsistent. This study evaluated the diagnostic yield of the medical workup performed in children and adolescents presenting with first psychotic presentation at a tertiary medical center. We conducted a retrospective cohort study using electronic medical records from Soroka University Medical Center, Israel. All patients aged 5-18 years who presented to the pediatric emergency department or were admitted with a first-time diagnosis of psychosis between 2008 and 2023 were included (n = 235). Clinical, laboratory, neuroimaging, and electroencephalographic findings were reviewed to determine the diagnostic yield of each investigation. The cohort had a high prevalence of pre-existing neurodevelopmental and medical comorbidities. Urine toxicology identified substance-related findings in 19 patients (8.1%), predominantly cannabinoids. Routine laboratory investigations did not otherwise identify an underlying medical etiology. Two patients had corticosteroid-induced psychosis. Neuroimaging (77%) identified clinically explanatory findings in three patients (1.3%), all of whom had neurological abnormalities or atypical clinical features. EEG (48%) did not identify the etiology of psychosis in any case. In children and adolescents with first psychotic presentation, the medical evaluation should be guided by clinical findings and toxicology screening rather than routine extensive testing. Neuroimaging and electroencephalography rarely identify an underlying medical cause in the absence of neurological abnormalities or atypical clinical features, supporting a selective, clinically guided diagnostic approach.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.